Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Autologous blood or platelet-rich plasma injections
Platelet-rich plasma (PRP) and whole blood injections are treatments that have been utilized for a variety of healing applications in sports medicine and orthopedic medicine.
Status: Decision completed
Decision summary
Autologous blood and platelet-rich plasma are not covered for any indications.
Documentation
| Type | Materials |
|---|---|
| Assessment (2023) | |
| Assessment (2016) |
Assessment timeline
- Draft key questions published: October 13, 2022
- Public comment period: October 13 to 27, 2022
- Final key questions published: November 29, 2022
- Draft report published: May 11, 2023
- Public comment period: May 11 to June 12, 2023
- Final report published: June 26, 2023
- HTCC public meeting: July 21, 2023
- Draft findings and decision published: July 27, 2023
- Public comment period: July 27 to August 10, 2023
- Final findings and decision published: November 20, 2023
All future dates are estimates and subject to change.